REDHILL BIOPHARMA LTD. Inventories At Fair Value Less Costs To Sell
REDHILL BIOPHARMA LTD. (RDHL) had Inventories At Fair Value Less Costs To Sell of $4.40 million as of 2023-12-31, per its 20-F filed 2024-04-08.
Discontinued › Notes › Inventory
ifrs-full:InventoriesAtFairValueLessCostsToSell · last filed 2024-04-08
- 2023-12-31: Inventories At Fair Value Less Costs To Sell $4.40M.
- 2022-12-31: Inventories At Fair Value Less Costs To Sell $9.70M.
- 2021-12-31: Inventories At Fair Value Less Costs To Sell $7.70M.
- 2020-12-31: Inventories At Fair Value Less Costs To Sell $5.20M.
| Period end | Inventories At Fair Value Less Costs To Sell |
|---|---|
| 2023-12-31 | $4.40M 20-F · filed 2024-04-08 |
| 2022-12-31 | $9.70M 20-F · filed 2024-04-08 |
| 2021-12-31 | $7.70M 20-F · filed 2024-04-08 |
| 2020-12-31 | $5.20M 20-F · filed 2022-03-17 |
| 2019-12-31 | $900.00K 20-F · filed 2021-03-18 |
| 2018-12-31 | $1.00M 20-F · filed 2020-03-04 |
| 2017-12-31 | $800.00K 20-F · filed 2019-02-26 |